TXTL news

Latest 1 stories · newest Sep 23, 2026

TXTL

Zymeworks sued for failing to pay contingent value rights (CVRs)

Zymeworks Inc. is being sued by acquisition target Theravance Biopharma after failing to pay out agreed-upon contingent value rights to shareholders following a 2026 merger. The filing confirms a breach of contract claims regarding the Merger Agreement and subsequent CVR obligations.

Legal Sep 23, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same TXTL feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/TXTL/newsSTART FREE